Search results
Results from the WOW.Com Content Network
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training ...
One recent study suggests that ADHD medication can help boost cognitive function. ... The research looked at both stimulant and non-stimulant drugs that doctors can prescribe long-term for the ...
What Is Adderall? Adderall is a brand name for a medication that contains a combination of dextroamphetamine and amphetamine. Most commonly prescribed for ADHD, Adderall can also be used to treat ...
If you’ve been diagnosed with ADHD, your healthcare provider may prescribe an ADHD medication such as Adderall to treat your symptoms and help you stay focused on tasks. While Adderall is ...
In 2021, it was the 231st most commonly prescribed medication in the United States, with more than 1 million prescriptions. [12] [13] Guanfacine is FDA-approved for monotherapy treatment of ADHD, [3] as well as being used for augmentation of other treatments, such as stimulants. [9]
This is a list of investigational attention deficit hyperactivity disorder drugs, or drugs that are currently under development for clinical use in the treatment of attention deficit hyperactivity disorder (ADHD) but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in ...
Millions of children and adults in the United States are prescribed medications to treat ADHD, a neurological disorder which causes differences in the brain that affect executive functioning.
Large, high quality research has found small differences in the brain between ADHD and non-ADHD patients. [1] [15] Jonathan Leo and David Cohen, critics who reject the characterization of ADHD as a disorder, contended in 2003 and 2004 that the controls for stimulant medication usage were inadequate in some lobar volumetric studies, which makes it impossible to determine whether ADHD itself or ...